Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies

References

• Feldman RD. Heart Disease in Women: Unappreciated Challenges, GPER as a New Target. International journal of molecular sciences 2016; 17(5).
   Web of Science ®Google Scholar
• Schneider AP, 2nd, Zainer CM, Kubat CK, Mullen NK, Windisch AK. The breast cancer epidemic: 10 facts. The Linacre quarterly 2014; 81(3): 244–77.
   PubMedGoogle Scholar
• Sorensen GV, Ganz PA, Cole SW, Pedersen LA, Sorensen HT, Cronin-Fenton DP et al. Use of beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013; 31(18): 2265–72.
   PubMed Web of Science ®Google Scholar
• Devore EE, Kim S, Ramin CA, Wegrzyn LR, Massa J, Holmes MD et al. Antihypertensive medication use and incident breast cancer in women. Breast cancer research and treatment 2015; 150(1): 219–29.
   PubMed Web of Science ®Google Scholar
• Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P et al. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer causes & control : CCC 2010; 21(10): 1615–24.
   PubMed Web of Science ®Google Scholar
• Azoulay L, Soldera S, Yin H, Bouganim N. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study. Epidemiology (Cambridge, Mass.) 2016; 27(4): 594–601.
   PubMed Web of Science ®Google Scholar
• Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast cancer research and treatment 2011; 129(2): 549–56.
   PubMed Web of Science ®Google Scholar
• Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N et al. Hypertension, diuretics and breast cancer risk. Journal of human hypertension 2006; 20(10): 727–32.
   PubMed Web of Science ®Google Scholar
• Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. Journal of hypertension 2000; 18(3): 249–54.
   Google Scholar
• Lanas A, Alcedo Gonzalez J. [Chemoprevention in adenocarcinoma of the esophagus]. Acta gastroenterologica Latinoamericana 2007; 37(1): 37–48.
   PubMedGoogle Scholar
• Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of clinical epidemiology 2008; 61(8): 763–9.
   PubMed Web of Science ®Google Scholar
• Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR et al. A review on prescribing patterns of antihypertensive drugs. Clinical hypertension 2015; 22: 7.
   PubMedGoogle Scholar
• Sieri S, Chiodini P, Agnoli C, Pala V, Berrino F, Trichopoulou A et al. Dietary fat intake and development of specific breast cancer subtypes. Journal of the National Cancer Institute 2014; 106(5).
   Google Scholar
• Field AE, Byers T, Hunter DJ, Laird NM, Manson JE, Williamson DF et al. Weight cycling, weight gain, and risk of hypertension in women. American journal of epidemiology 1999; 150(6): 573–9.
   PubMed Web of Science ®Google Scholar
• Pereira A, Garmendia ML, Alvarado ME, Albala C. Hypertension and the risk of breast cancer in Chilean women: a case-control study. Asian Pacific journal of cancer prevention : APJCP 2012; 13(11): 5829–34.
   PubMedGoogle Scholar
• Lindgren A, Pukkala E, Tuomilehto J, Nissinen A. Incidence of breast cancer among postmenopausal, hypertensive women. International journal of cancer 2007; 121(3): 641–4.
   PubMed Web of Science ®Google Scholar
• Kabat GC, Kim M, Adams-Campbell LL, Caan BJ, Chlebowski RT, Neuhouser ML et al. Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. The American journal of clinical nutrition 2009; 90(1): 162–9.
   PubMed Web of Science ®Google Scholar
• Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World journal of cardiology 2014; 6(7): 517–30.
   PubMedGoogle Scholar
• Hamet P. Cancer and hypertension: a potential for crosstalk? Journal of hypertension 1997; 15(12 Pt 2): 1573–7.
   PubMed Web of Science ®Google Scholar
• Chiang YY, Chen KB, Tsai TH, Tsai WC. Lowered cancer risk with ACE inhibitors/ARBs: a population-based cohort study. Journal of clinical hypertension (Greenwich, Conn.) 2014; 16(1): 27–33.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Jackson EK, Gillespie DG, Zacharia LC, Fingerle J, Dubey RK. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs. Hypertension 2002; 39(4): 874–9.
   PubMed Web of Science ®Google Scholar
• Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer research 2010; 70(18): 7042–52.
   PubMed Web of Science ®Google Scholar
• Choy C, Raytis JL, Smith DD, Duenas M, Neman J, Jandial R et al. Inhibition of beta2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative beta-blockade. Oncology reports 2016; 35(6): 3135–42.
   Google Scholar
• Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010; 1(7): 628–38.
   PubMed Web of Science ®Google Scholar
• Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011; 29(19): 2645–52.
   PubMed Web of Science ®Google Scholar
• Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, Norgaard M, McLaughlin JK et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast cancer research and treatment 2006; 97(3): 231–6.
   PubMed Web of Science ®Google Scholar